Osaic Holdings’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$161 Hold
12
– – ﹤0.01% 7881
2026
Q2
$197 Buy
12
+6
+100% +$79 ﹤0.01% 7784
2026
Q1
$78 Buy
+6
New +$80 ﹤0.01% 7744
2025
Q2
$70 Buy
+10
New +$43 ﹤0.01% 7592

Other funds holding CTNM

Osaic Holdings's CTNM Position: Q3 2026 in Review

Osaic Holdings held its Contineum Therapeutics (CTNM) position steady in Q3 2026 at 12 shares worth $161. The position accounts for ﹤0.01% of the portfolio, ranked #7881.

Osaic Holdings first reported a position in CTNM in Q2 2025 and has held it in 4 quarters since. The position peaked at $197 in Q2 2026. 118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • Osaic Holdings held 12 shares of Contineum Therapeutics worth $161 as of Q3 2026.
  • Osaic Holdings left its Contineum Therapeutics share count unchanged in Q3 2026.
  • Contineum Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7881 holding.
  • Osaic Holdings first reported a position in Contineum Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Osaic Holdings's Contineum Therapeutics position peaked at $197 in Q2 2026.
  • 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.